Key facts
- It has raised $11.6M; the latest was Accelerator/Incubator in Sep 2024.
- Notable investors include Google for Startups, Accenture Ventures, Capria Ventures, Sarona Ventures, Apple Core Holdings — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Geneyx
- ·The full record, as it builds
Funding rounds
No funding rounds for Geneyx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Geneyx
Developer of an artificial intelligence-based analytics platform intended to promote an end-to-end technique for secured genetic data resources. The company's platform provides biomedical interpretation capabilities for the genome to enhance that scope, enabling clinicians to access accurate diagnoses while reducing turn-around time to minutes.
- Sector
- Healthcare
- HQ
- Herzliya, Israel
- Founded
- 2018
- Employees
- 30
- Website
- geneyx.com/
- Ownership
- Privately Held (backing)
Geneyx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Geneyx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Geneyx in its N-PORT filings yet. We sweep new filings monthly.